Among IL-1 Inhibitors for Treating VEXAS, This One Stands Out

By News Health
3 hours Ago

(MedPage Today) — Canakinumab (Ilaris) may be the better option than anakinra (Kineret) when treating the rare disease called VEXAS syndrome with an interleukin-1 (IL-1) inhibitor, a multinational study indicated.
Among 47 VEXAS patients treated…

Source link : https://www.medpagetoday.com/rheumatology/generalrheumatology/117612

Author :

Publish date : 2025-09-23 21:29:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Period Choices: Pads, menstrual cups, pants and tampons

Hyped Weight Loss Study Retracted

Study Sheds Light on Drinking and Dementia Risk

The Fascinating Precision Process of Making Drugs in Space

You Are What (Plastics) You Eat

What we know, and don't, about the link between painkillers and autism